179 related articles for article (PubMed ID: 37427544)
1. Review of industrially recognized polymers and manufacturing processes for amorphous solid dispersion based formulations.
Saha SK; Joshi A; Singh R; Dubey K
Pharm Dev Technol; 2023 Sep; 28(7):678-696. PubMed ID: 37427544
[TBL] [Abstract][Full Text] [Related]
2.
Jermain SV; Lowinger MB; Ellenberger DJ; Miller DA; Su Y; Williams RO
Mol Pharm; 2020 Aug; 17(8):2789-2808. PubMed ID: 32520562
[TBL] [Abstract][Full Text] [Related]
3. Expanding the Application and Formulation Space of Amorphous Solid Dispersions with KinetiSol®: a Review.
Ellenberger DJ; Miller DA; Williams RO
AAPS PharmSciTech; 2018 Jul; 19(5):1933-1956. PubMed ID: 29846889
[TBL] [Abstract][Full Text] [Related]
4. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
[TBL] [Abstract][Full Text] [Related]
5. Multiple Linear Regression Modeling To Predict the Stability of Polymer-Drug Solid Dispersions: Comparison of the Effects of Polymers and Manufacturing Methods on Solid Dispersion Stability.
Fridgeirsdottir GA; Harris RJ; Dryden IL; Fischer PM; Roberts CJ
Mol Pharm; 2018 May; 15(5):1826-1841. PubMed ID: 29533634
[TBL] [Abstract][Full Text] [Related]
6. Navigating the Solution to Drug Formulation Problems at Research and Development Stages by Amorphous Solid Dispersion Technology.
Tripathi D; B H MP; Sahoo J; Kumari J
Recent Adv Drug Deliv Formul; 2023 Dec; ():. PubMed ID: 38062659
[TBL] [Abstract][Full Text] [Related]
7. Melt extrusion with poorly soluble drugs.
Shah S; Maddineni S; Lu J; Repka MA
Int J Pharm; 2013 Aug; 453(1):233-52. PubMed ID: 23178213
[TBL] [Abstract][Full Text] [Related]
8. Kollidon® VA 64 and Soluplus® as modern polymeric carriers for amorphous solid dispersions.
Strojewski D; Krupa A
Polim Med; 2022; 52(1):19-29. PubMed ID: 35766434
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of the potential of poly(2-ethyl-2-oxazoline) as carrier in the formulation of amorphous solid dispersions of poorly soluble drugs.
Boel E; Smeets A; Vergaelen M; De la Rosa VR; Hoogenboom R; Van den Mooter G
Eur J Pharm Biopharm; 2019 Nov; 144():79-90. PubMed ID: 31499162
[TBL] [Abstract][Full Text] [Related]
10. Recent studies on the processes and formulation impacts in the development of solid dispersions by hot-melt extrusion.
Tran PHL; Lee BJ; Tran TTD
Eur J Pharm Biopharm; 2021 Jul; 164():13-19. PubMed ID: 33887388
[TBL] [Abstract][Full Text] [Related]
11. Amorphous solid dispersions: Stability mechanism, design strategy and key production technique of hot melt extrusion.
Han J; Tang M; Yang Y; Sun W; Yue Z; Zhang Y; Zhu Y; Liu X; Wang J
Int J Pharm; 2023 Nov; 646():123490. PubMed ID: 37805146
[TBL] [Abstract][Full Text] [Related]
12. A systematic and robust assessment of hot-melt extrusion-based amorphous solid dispersions: Theoretical prediction to practical implementation.
Alzahrani A; Nyavanandi D; Mandati P; Youssef AAA; Narala S; Bandari S; Repka M
Int J Pharm; 2022 Aug; 624():121951. PubMed ID: 35753536
[TBL] [Abstract][Full Text] [Related]
13. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug.
Mitra A; Li L; Marsac P; Marks B; Liu Z; Brown C
Int J Pharm; 2016 May; 505(1-2):107-14. PubMed ID: 27012984
[TBL] [Abstract][Full Text] [Related]
14. Innovations in Thermal Processing: Hot-Melt Extrusion and KinetiSol® Dispersing.
Tan DK; Davis DA; Miller DA; Williams RO; Nokhodchi A
AAPS PharmSciTech; 2020 Nov; 21(8):312. PubMed ID: 33161479
[TBL] [Abstract][Full Text] [Related]
15. Molecular-Level Examination of Amorphous Solid Dispersion Dissolution.
Faiz Afzal MA; Lehmkemper K; Sobich E; Hughes TF; Giesen DJ; Zhang T; Krauter CM; Winget P; Degenhardt M; Kyeremateng SO; Browning AR; Shelley JC
Mol Pharm; 2021 Nov; 18(11):3999-4014. PubMed ID: 34570503
[TBL] [Abstract][Full Text] [Related]
16. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
[TBL] [Abstract][Full Text] [Related]
17. Chrono modulated multiple unit particulate systems (MUPS) via a continuous hot melt double extrusion technique: Investigation of the formulation and process suitability.
Kallakunta VR; Sarabu S; Dudhipala N; Janga KY; Bandari S; Zhang F; Repka MA
Eur J Pharm Biopharm; 2021 Nov; 168():184-194. PubMed ID: 34464695
[TBL] [Abstract][Full Text] [Related]
18. Continuous Manufacturing and Molecular Modeling of Pharmaceutical Amorphous Solid Dispersions.
Nambiar AG; Singh M; Mali AR; Serrano DR; Kumar R; Healy AM; Agrawal AK; Kumar D
AAPS PharmSciTech; 2022 Sep; 23(7):249. PubMed ID: 36056225
[TBL] [Abstract][Full Text] [Related]
19. Thermal Stability of Amorphous Solid Dispersions.
Jelić D
Molecules; 2021 Jan; 26(1):. PubMed ID: 33466393
[TBL] [Abstract][Full Text] [Related]
20. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
